James Patrick Kelly, EVP & Chief Financial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 8,809 shares at $26.31 ($232K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Seasonal sale ($232k) by EVP & Chief Financial Officer — this insider has traded VNDA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.31 | 3,313 | $87K | 37.5% |
| 2 | $26.94 | 1,129 | $30K | 13.1% |
| 3 | $26.94 | 1,129 | $30K | 13.1% |
| 4 | $26.09 | 1,619 | $42K | 18.2% |
| 5 | $26.09 | 1,619 | $42K | 18.2% |
| Total | $26.39 avg | 8,809 |
| $232K |
| 100% |
| Filing → |
| VNDA | SELL | 2019-03-04 | $548K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |
| VNDA | SELL | 2018-03-02 | $319K | — | Filing → |